BioSpace News Archive

NanoTemper Technologies, creator of biophysical tools for drug discovery, proudly announced the launch of their highly anticipated Biotinylated Target Labeling Kit, expanding the molecular interaction analysis toolkit for scientists working with complex or undruggable targets, filling a vital gap in screening and hit validation workflows in the pharma industry.

Liberation Labs, broke ground on its first commercial-scale, purpose-built, precision fermentation biomanufacturing facility in Richmond, Indiana.

Bexion Pharmaceuticals, Inc. announced today that the Company will be represented at the ESMO World Congress on Gastrointestinal Cancer 2023 taking place on June 28 – July 1, 2023, in Barcelona, Spain.

Ardelyx, Inc. announced that on June 28, 2023, the compensation committee of the company’s board of directors granted four new non-executive employees options to purchase an aggregate of 66,483 shares of the company’s common stock, and granted ten new non-executive employees an aggregate of 102,250 Restricted Stock Units.

In Addition, Board has Accepted Recent Director Resignations and has Initiated a Search for New Directors Aurinia Pharmaceuticals Inc. announced that its Board of Directors has initiated an exploration of strategic alternatives.

Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”) today announced that financial results for the second quarter of fiscal year 2023 will be released after the market closes on Thursday, August 10th.

Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18 mg/mL), the first generic version of Merck’s Noxafil® in the U.S., following final approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application.

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the MIT-E trial of vatiquinone for the treatment of mitochondrial disease associated seizures (MDAS) failed to achieve its primary endpoint of reduction in observable motor seizures.

Nuseed Nutritional US Inc., a wholly-owned subsidiary of Nufarm Limited (ASX:NUF), welcomes the Norwegian Food Safety Authority’s (NFSA) decision to grant the approval of Aquaterra® Omega-3 oil for use in fish feed applications.

AVITA Medical, Inc. announced its submission of a premarket approval supplement to the U.S. Food and Drug Administration for RECELL GO™.